Rebecca J Ingram Selected Research

Cutaneous anthrax

1/2020	Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes.
1/2015	Natural cutaneous anthrax infection, but not vaccination, induces a CD4(+) T cell response involving diverse cytokines.
5/2014	Anthrax lethal factor as an immune target in humans and transgenic mice and the impact of HLA polymorphism on CD4+ T cell immunity.
4/2010	Natural exposure to cutaneous anthrax gives long-lasting T cell immunity encompassing infection-specific epitopes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca J Ingram Research Topics

Disease

15	Infections 01/2020 - 06/2009
8	Anthrax 01/2020 - 04/2010
4	Cutaneous anthrax 01/2020 - 04/2010
3	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 09/2017
3	Bacterial Infections (Bacterial Infection) 01/2019 - 04/2010
2	Inflammation (Inflammations) 01/2021 - 01/2018
2	Lung Injury 02/2016 - 06/2014
2	Pseudomonas Infections 02/2016 - 01/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Dysbiosis 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2016
1	Acute Lung Injury 06/2014
1	Central Nervous System Diseases (CNS Diseases) 10/2013
1	Wounds and Injuries (Trauma) 07/2012
1	Bacteremia 06/2009
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2009
1	Sepsis (Septicemia) 06/2009
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2006

Drug/Important Bio-Agent (IBA)

6	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 04/2010
5	EpitopesIBA 01/2020 - 11/2006
5	VaccinesIBA 01/2015 - 11/2006
4	AntigensIBA 01/2020 - 07/2012
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2006
3	anthrax toxin (anthrax lethal factor)IBA 01/2020 - 09/2010
3	Interleukin-17 (Interleukin 17)IBA 02/2016 - 06/2009
3	CytokinesIBA 01/2015 - 06/2009
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2019 - 01/2012
2	Peptides (Polypeptides)IBA 01/2015 - 05/2014
2	Anthrax Vaccines (Vaccines, Anthrax)IBA 01/2015 - 04/2010
2	Subunit VaccinesIBA 05/2014 - 09/2010
2	Immunodominant EpitopesIBA 05/2014 - 11/2006
1	cathepsin SIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2020
1	Capsules (Microcapsules)IBA 01/2020
1	CuprizoneIBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	hypothiocyanite ion (OSCN-)IBA 12/2018
1	LactoferrinIBA 12/2018
1	InflammasomesIBA 01/2018
1	Interferon Type IIBA 11/2017
1	ivacaftorIBA 09/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 09/2017
1	Antimicrobial PeptidesIBA 09/2017
1	VitaminsIBA 01/2017
1	LipocalinsIBA 01/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2015
1	Hepatitis B e AntigensIBA 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Fibroblast Growth Factor 7 FDA Link 06/2014
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 06/2014
1	AntibodiesIBA 05/2014
1	Heroin (Diamorphine)IBA 02/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	salicylhydroxamic acid (SHAM)IBA 07/2012
1	AminoglycosidesIBA 01/2012
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2010
1	Indicators and Reagents (Reagents)IBA 11/2006

Therapy/Procedure

1	Therapeutics 09/2017